Alcohol Research Consortium in HIV (ARCH) is comprised of two U24 and two UOI applications, and will address critical questions regarding the clinical epidemiology of hazardous alcohol use/abuse/dependence in HIV infection (Epidemiology Research Arm), and evaluate the comparative effectiveness of evidence- based alcohol reduction strategies in real world HIV clinic settings (Intervention Research Arm). This research builds upon the unique strengths of a well-established HIV clinical cohort, the CFAR Network of Integrated Clinical Systems (CNICS), comprised of 8 clinics and over 20,000 HIV-infected individuals across the United States. This dynamic cohort provides an ideal scientific platform for long-term study of HIV and alcohol through the collection of comprehensive clinical data and specimens as well as uniformly-collected patient reported outcomes as a part of the Patient Reported Outcomes Measurement Information System initiative. An Epidemlology/Biostatistics Core will be led by experts in epidemiology and biostatistics with specific focus on HIV research. It will provide critical support for the scientific agenda of the U01 applications and focus on development of innovative analytic strategies that will maximize new clinical and scientific knowledge. The U24 at the heart of ARCH is the Administrative Core (AC), the focus of this application. ARCH-AC will provide the critical infrastructure to coordinate and facilitate the consortium's scientific goals. Structure will include: an executive committee;a steering committee;key scientific working groups to conceptualize and implement study aims;and a community advisory board. ARCH-AC is co-led by national experts in alcohol use disorders and HIV, who have over 40 years of combined scientific experience in conducting epidemiologic and clinical research in HIV/AIDS. The AC provides the critical infrastructure to: 1) conceptualize, facilitate and oversee the implementation of the scientific epidemiologic and interventional aims;2) promote communication and collaboration among ARCH components and investigators;3) manage and optimize access to ARCH resources, particularly the data repositories, epidemiologic/ biostatistics support and the investigational expertise;and 4) provide the support for dissemination of ARCH findings.

Public Health Relevance

The Alcohol Research Consortium in HIV combines an unparalleled breadth and depth of investigator expertise with a comprehensive and diverse multisite US HIV cohort to create a world-class consortium that will accelerate advancement of new knowledge of the epidemiology of alcohol use and HIV, and evaluate the comparative effectiveness of evidenced-based psychosocial and pharmacological alcohol treatments.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Resource-Related Research Projects--Cooperative Agreements (U24)
Project #
5U24AA020801-03
Application #
8526296
Study Section
Special Emphasis Panel (ZAA1-DD (04))
Program Officer
Roach, Deidra
Project Start
2011-09-15
Project End
2016-08-31
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
3
Fiscal Year
2013
Total Cost
$369,661
Indirect Cost
$72,249
Name
Johns Hopkins University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Fredericksen, Rob J; Mayer, Kenneth H; Gibbons, Laura E et al. (2018) Development and Content Validation of a Patient-Reported Sexual Risk Measure for Use in Primary Care. J Gen Intern Med 33:1661-1668
Yang, Cui; DeBartolo, Peter; McCaul, Mary E et al. (2018) The role of personal and household members' substance use in health-related quality of life in women living with HIV/AIDS. AIDS Care 30:473-479
Bilal, Usama; McCaul, Mary E; Crane, Heidi M et al. (2018) Predictors of Longitudinal Trajectories of Alcohol Consumption in People with HIV. Alcohol Clin Exp Res 42:561-570
Lee, Kristen; Hutton, Heidi E; Lesko, Catherine R et al. (2018) Associations of Drug Use, Violence, and Depressive Symptoms with Sexual Risk Behaviors Among Women with Alcohol Misuse. Womens Health Issues 28:367-374
Merlin, Jessica S; Long, Dustin; Becker, William C et al. (2018) Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment Outcomes. J Acquir Immune Defic Syndr 79:77-82
McCaul, Mary E; Wand, Gary S (2018) Detecting Deception in Our Research Participants: Are Your Participants Who You Think They Are? Alcohol Clin Exp Res 42:230-237
Lesko, Catherine R; Keil, Alexander P; Moore, Richard D et al. (2018) Measurement of Current Substance Use in a Cohort of HIV-Infected Persons in Continuity HIV Care, 2007-2015. Am J Epidemiol 187:1970-1979
Vinikoor, Michael J; Zyambo, Zude; Muyoyeta, Monde et al. (2018) Point-of-Care Urine Ethyl Glucuronide Testing to Detect Alcohol Use Among HIV-Hepatitis B Virus Coinfected Adults in Zambia. AIDS Behav 22:2334-2339
Crane, Heidi M; Nance, Robin M; Merrill, Joseph O et al. (2017) Not all non-drinkers with HIV are equal: demographic and clinical comparisons among current non-drinkers with and without a history of prior alcohol use disorders. AIDS Care 29:177-184
Canan, Chelsea; Lesko, Catherine; Lau, Bryan (2017) Instrumental Variable Analyses and Selection Bias. Epidemiology 28:396-398

Showing the most recent 10 out of 37 publications